Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05589376

You and Me Healthy

You and Me Healthy Registry Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Accepted

Summary

The You and Me Healthy Registry provides a resource for collecting information on people currently living in the United States. The overall goal of the Registry is to create and engage a community of people who may be eligible for participation in future research studies aiming to answer research questions about COVID-19 and other conditions.

Detailed description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus responsible for the COVID-19 pandemic. In the United States (US) up until January 2022, \> 60 million people have been infected with the SARS-CoV-2 virus and \>800,000 died, with infections and deaths disproportionally affecting populations that have been historically marginalized1. Wide disparities also persist by race/ethnicity and age with COVID-19 testing and vaccine uptake related to social and structural factors, resulting in adverse health consequences. As public health measures have scaled up, mitigation strategies are increasingly being considered to reduce community spread of infection. These measures include rapid-result at-home tests, protective measures (masking, social distancing, increased hygiene), treatments, and contact-tracing and isolation. As the pandemic evolves, new discoveries, technologies, and strategies to combat COVID-19 are being implemented with limited backing of research data. To address this continued unmet public health need, the You and Me Healthy registry is being created to engage community members and serve as a way to provide and collect information from all people who are interested in engaging in upcoming research studies, including those related to COVID-19.

Conditions

Timeline

Start date
2022-09-08
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2022-10-21
Last updated
2025-11-26

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05589376. Inclusion in this directory is not an endorsement.